Mending Broken Hearts: A New Treatment Paradigm for Immune Checkpoint Inhibitor–Induced Myocarditis

This commentary discusses the rare, immune related adverse effect of myocarditis associated with immune checkpoint inhibitors (ICI). The authors propose a treatment paradigm that is based on the current management of the autoimmune condition, rheumatoid arthritis.

Circulation